Tidal Investments LLC Buys 36 Shares of Waters Co. (NYSE:WAT)

Tidal Investments LLC lifted its stake in shares of Waters Co. (NYSE:WAT) by 0.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,998 shares of the medical instruments supplier’s stock after purchasing an additional 36 shares during the period. Tidal Investments LLC’s holdings in Waters were worth $1,439,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Wilmington Savings Fund Society FSB acquired a new stake in Waters in the third quarter worth about $100,000. Sanctuary Advisors LLC grew its position in shares of Waters by 25.2% during the 3rd quarter. Sanctuary Advisors LLC now owns 2,433 shares of the medical instruments supplier’s stock worth $908,000 after buying an additional 490 shares during the period. Toronto Dominion Bank raised its stake in shares of Waters by 0.3% during the third quarter. Toronto Dominion Bank now owns 26,303 shares of the medical instruments supplier’s stock worth $9,466,000 after buying an additional 69 shares during the last quarter. Coldstream Capital Management Inc. lifted its holdings in Waters by 5.3% in the third quarter. Coldstream Capital Management Inc. now owns 2,982 shares of the medical instruments supplier’s stock valued at $1,076,000 after buying an additional 149 shares during the period. Finally, Geode Capital Management LLC boosted its stake in Waters by 1.2% in the third quarter. Geode Capital Management LLC now owns 1,416,683 shares of the medical instruments supplier’s stock valued at $508,123,000 after acquiring an additional 16,703 shares during the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Stock Performance

WAT opened at $360.43 on Thursday. The company has a debt-to-equity ratio of 1.14, a current ratio of 2.02 and a quick ratio of 1.38. The company has a market capitalization of $21.40 billion, a price-to-earnings ratio of 34.39, a P/E/G ratio of 6.92 and a beta of 1.01. The business’s 50-day moving average price is $366.89 and its two-hundred day moving average price is $337.26. Waters Co. has a 1 year low of $279.24 and a 1 year high of $397.02.

Waters (NYSE:WAT) last released its earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 EPS for the quarter, beating the consensus estimate of $2.68 by $0.25. The firm had revenue of $740.30 million for the quarter, compared to analysts’ expectations of $712.99 million. Waters had a return on equity of 49.93% and a net margin of 21.43%. The business’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.84 EPS. Equities analysts expect that Waters Co. will post 11.79 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have commented on WAT. Wells Fargo & Company upped their target price on shares of Waters from $380.00 to $415.00 and gave the company an “overweight” rating in a research report on Monday, November 4th. Evercore ISI increased their target price on Waters from $335.00 to $355.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. Barclays boosted their target price on Waters from $330.00 to $360.00 and gave the stock an “underweight” rating in a research report on Monday, November 4th. Sanford C. Bernstein lifted their price objective on shares of Waters from $345.00 to $360.00 and gave the stock a “market perform” rating in a research note on Monday, November 4th. Finally, Stifel Nicolaus boosted their price objective on shares of Waters from $332.00 to $360.00 and gave the company a “hold” rating in a report on Monday, November 4th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $375.85.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.